Miloš Marković
Impact in
- Immunology top 10%
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Immunology 13
- T-cell and B-cell Immunology 5
-
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 6
- Co-authors
- Djordje Miljković (10 shared papers)Vladimir Trajković (10 shared papers)Zorica Ramić (9 shared papers)Marija Mostarica Stojković (9 shared papers)Dušan Popadić (11 shared papers)Stanislava Stošić‐Grujičić (4 shared papers)Tatjana Samardžić (2 shared papers)Marija Mostarica‐Stojković (6 shared papers)
In The Last Decade
Miloš Marković
47 papers receiving 606 citations
Peers
Comparison fields: 5 of 99
- Immunology 219
- Neurology 84
- Biological Psychiatry 24
- Pathology and Forensic Medicine 102
- Infectious Diseases 101
Countries citing papers authored by Miloš Marković
This map shows the geographic impact of Miloš Marković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miloš Marković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miloš Marković more than expected).
Fields of papers citing papers by Miloš Marković
This network shows the impact of papers produced by Miloš Marković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miloš Marković. The network helps show where Miloš Marković may publish in the future.
Co-authors
The 25 scholars most cited alongside Miloš Marković, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 86 | |
| 2 | 2004 | 67 | |
| 3 | 2006 | 47 | |
| 4 | 2022 | 28 | |
| 5 | 2003 | 23 | |
| 6 | 2008 | 20 | |
| 7 | 2009 | 20 | |
| 8 | 2001 | 20 | |
| 9 | 2018 | 19 | |
| 10 | 2012 | 19 | |
| 11 | 2015 | 19 | |
| 12 | 2002 | 16 | |
| 13 | 2003 | 16 | |
| 14 | 2022 | 14 | |
| 15 | 2016 | 14 | |
| 16 | 2014 | 13 | |
| 17 | 2022 | 13 | |
| 18 | 2023 | 12 | |
| 19 | 2009 | 12 | |
| 20 | 2015 | 12 |
About Miloš Marković
Miloš Marković is a scholar working on Immunology, Infectious Diseases, Epidemiology, Pathology and Forensic Medicine and Oncology, having authored 50 papers that have together received 610 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (6 papers), Multiple Sclerosis Research Studies (6 papers), T-cell and B-cell Immunology (5 papers), Vaccine Coverage and Hesitancy (5 papers), Pneumonia and Respiratory Infections (5 papers), Respiratory viral infections research (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Immunology (219 citations), Neurology (84 citations), Biological Psychiatry (24 citations), Pathology and Forensic Medicine (102 citations) and Infectious Diseases (101 citations). Miloš Marković has collaborated with scholars based in Serbia, Czechia and Croatia. Frequent co-authors include Djordje Miljković, Vladimir Trajković, Zorica Ramić, Marija Mostarica Stojković, Dušan Popadić, Stanislava Stošić‐Grujičić, Tatjana Samardžić, Marija Mostarica‐Stojković, Vladimir Petrović and Mioljub Ristić. Their work appears in journals such as Vaccines, PLoS ONE, Journal of Neuroimmunology, European Journal of Pharmacology and Glia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.